Researchers suggest improved assessment of depressive disorders in people with HIV/AIDS

Image
ANI Health
Last Updated : Apr 08 2020 | 10:40 AM IST

People diagnosed with HIV/AIDS are more prone to the risks of depressive disorders. However, a literature review from the Harvard Review of Psychiatry, suggests that in many cases, these conditions go "unrecognised or untreated".

As per the reports of Gustavo C. Medeiros, MD, of the University of Texas Southwestern Medical Center, Dallas, and colleagues, proper diagnosis and management are essential to reduce negative health effects of depression in patients with HIV/AIDS.

Based on an analysis of 125 research publications, "We provide evidence-based recommendations to improve the assessment and management of depressive disorders in seropositive persons," the researchers write.

Depressive disorders are linked to negative health outcomes including poorer compliance with antiretroviral therapy, lower immune function (CD4 cell count), and a higher mortality rate.

Dr. Medeiros and colleagues seek to provide an "updated, practical, and global overview" of depression in HIV/AIDS.

Depressive disorders are vastly underdiagnosed in HIV/AIDS," according to the authors.

Patient assessment is complex due to the overlap between depression and HIV/AIDS symptoms, including fatigue, insomnia, and reduced appetite. Hence, making the correct diagnosis is essential for providing the appropriate treatment.

Depressive symptoms in patients with HIV/AIDS also may be due to other medical conditions, medications or addictive substances, adjustment disorder, or other psychiatric disorders.

Direct brain damage caused by HIV, as well as psychosocial factors such as chronic stress, HIV-related stigma, and social isolation, can also be other contributing factors.

Accessing the treatment part, one study reported that only seven percent of HIV-positive patients with MDD (Major Depressive Disorder) had access to adequate treatment.

Selective serotonin reuptake inhibitors (SSRIs) are the first-choice medications; other antidepressants may be used but require close monitoring for side effects and drug interactions.

Individual or group psychotherapy can also be counted as a helpful treatment method. It's also essential to ensure proper management of HIV/AIDS and related medical conditions.

The combination of depression and HIV/AIDS is strongly linked to suicide, with rates eight to ten times higher than in the general population. Depression also poses special challenges in adolescents and older adults with HIV/AIDS.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 08 2020 | 10:27 AM IST

Next Story